Photobiomodulation therapy for androgenetic alopecia: A clinician's guide to home-use devices cleared by the Federal Drug Administration.
PMID : 29020478 ·
E, r, i, n, , M, , D, o, d, d, ;, , M, a, r, g, o, , A, , W, i, n, t, e, r, ;, , M, a, r, i, a, , K, , H, o, r, d, i, n, s, k, y, ;, , N, e, i, l, , S, , S, a, d, i, c, k, ;, , R, o, n, d, a, , S, , F, a, r, a, h
Publicité
Résumé
The market for home-use photobiomodulation devices to treat androgenetic alopecia has rapidly expanded, and the Food and Drug Administration (FDA) has recently cleared many devices for this purpose. Patients increasingly seek the advice of dermatologists regarding the safety and efficacy of these hair loss treatments. The purpose of this guide was threefold: (1) to identify all home-use photobiomodulation therapy devices with FDA-clearance for treatment of androgenetic alopecia; (2) to review de
Publicité
Source officielle
Voir sur PubMed →Données issues de PubMed / NCBI. Pour le texte intégral et les informations les plus récentes, consultez toujours la notice officielle.